- Country: Brazil
- Summary: Eventual Acquisition of High Cost Drugs for Hgec's High Cost Pharmacy.
- BRT Ref No: 123726380
- Deadline: 12 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90015/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Possible acquisition of high cost drugs for HGEC's high cost pharmacy.
UASG Code: 160223
Notice from: 07/31/2025 from 08:00 to 12:00 and from 13:00 to 15:00
Proposal Delivery: From 07/31/2025 to 08:00
Formoterol Fumarato, Composition associated with Budesonide, concentration 6 mcg +200 mcg/ dose, pharmaceutical form aerosol suspension for inhalation, additional characteristics with inhaler vial
Quantity: 36
Buprenorphine, 10 mg concentration, transdermal adhesive pharmaceutical form
Quantity: 96
Buprenorfine, concentration 20 mg, transdermal adhesive pharmaceutical form
Quantity: 96
Dabigatrana Etexilato, concentration 110 mg
Quantity: 1440
Duloxetine, concentration 30 mg, pharmaceutical form slow release microgranles
Quantity: 2160
Duloxetine, concentration 60 mg, pharmaceutical form of release micrograne Slow
Quantity: 4320
Dulaglutide, 1.5 mg/ ml concentration, pharmaceutical form injectable solution, additional characteristics in completed syringe, additional with application system
Quantity: 96
Pagliflozine, composition associated with linagliptin, concentration 25 mg + 5 mg
Quantity: 1440
EZETIMIBA, Concentration 10 mg
Quantity: 720
Flutasone, fuorate composition, concentration 27.5 mcg/dose, pharmaceutical form nasal spray
Quantity: 48
Hemin, concentration* 350 mg, pharmaceutical form lipyl powder for injectable
Quantity: 14
Insulin, glulisin origin, fast action type, concentration 100 IU/ml, Pharmaceutical form injectable solution, additional characteristic with applicator
Quantity: 230
Insulin, type glargine, concentration 300 IU/ml, pharmaceutical form injectable solution, additional characteristic with applicator
Ixequizumab, concentration 80 mg/ml, pharmaceutical form solution Injectable, additional characteristics filled syringe
Quant ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEventual Acquisition of High Cost Drugs for Hgec's High Cost Pharmacy. - Brazil Tender
The MINISTRY OF DEFENSE, a Government sector organization in Brazil, has announced a new tender for Eventual Acquisition of High Cost Drugs for Hgec's High Cost Pharmacy.. This tender is published on BrazilTenders under BRT Ref No: 123726380 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-12.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
